Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00724568 |
|---|---|
| Brief Title: | Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma (RVDD) |
| First Submitted : | April 11, 2008 |
| First Submitted that Met QC Criteria : | July 28, 2008 |
| First Posted : | July 29, 2008 (Estimate) |
| Results First Submitted : | September 3, 2014 |
| Results First Submitted that Met QC Criteria : | September 3, 2014 |
| Results First Posted : | September 10, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 3, 2017 |
| Last Update Posted : | June 2, 2017 |